Suche
Kategorie
Erscheinungsjahr
85384 Treffer
×
Publikationen
×
Johannes Gutenberg-Universität Mainz
×
Universität Trier
×
Hochschule Mainz
×
Hochschule Trier
×
Theologische Fakultät Trier
- Kowalski, Christoph; Graeven, Ullrich; von Kalle, Christof et al.
- Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
- BMC CANCER. Bd. 17. 2017
- Schupp, J.; Foerster, F.; Voigt, M. et al.
- Targeting tumor-associated macrophages in a human melanoma model using siRNA and small molecules encapsulated in nanoparticles to achieve an antitumor response
- EXPERIMENTAL DERMATOLOGY. Bd. 26. H. 3. 2017 S. E66-E67
- Pohlit, Hannah; Worm, Matthias; Langhanki, Jens et al.
- Silver Oxide Mediated Monotosylation of Poly(ethylene glycol) (PEG): Heterobifunctional PEG via Polymer Desymmetrization
- MACROMOLECULES. Bd. 50. H. 23. 2017 S. 9196-9206
- Ascierto, Paolo A.; Del Vecchio, Michele; Robert, Caroline et al.
- Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
- LANCET ONCOLOGY. Bd. 18. H. 5. 2017 S. 611-622
- Farkas, H.; Martinez-Saguer, I.; Bork, K. et al.
- International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
- ALLERGY. Bd. 72. H. 2. 2017 S. 300-313
- Loquai, Carmen; Schmidtmann, Irene; Garzarolli, Marlene et al.
- Interactions from complementary and alternative medicine in patients with melanoma
- MELANOMA RESEARCH. Bd. 27. H. 3. 2017 S. 238-242
- Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep et al.
- Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
- EUROPEAN JOURNAL OF CANCER. Bd. 75. 2017 S. 47-55
- Cosgarea, I; Zimmer, L.; Weide, B. et al.
- Interleukin-2 and Checkpoint Inhibition as a successful Therapy Sequence for metastatic Melanoma: Case Report and retrospective Analysis in 52 Patients
- JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 15. 2017 S. 16-17
- Miller, M.; Sahin, U.; Derhovanessian, E. et al.
- IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
- ANNALS OF ONCOLOGY. Bd. 28. 2017
- Staubach, P.; Metz, M.; Chapman-Rothe, N. et al.
- Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (vol 71, pg 1135, 2016)
- ALLERGY. Bd. 72. H. 9. 2017 S. 1430-1430